Introduction {#section1-2192568218799058}
============

Spondylodiscitis is an infectious disease of the intervertebral disc space and adjacent vertebral end plates.^[@bibr1-2192568218799058]^ Most patients with discitis present initially with back pain and often have significant delays in time to diagnosis.^[@bibr2-2192568218799058]^ Severity of back pain can be quite significant, resulting in poor quality of life and disability scores.^[@bibr3-2192568218799058]^ Continued bone and disc destruction from prolonged, chronic infection may progress to significant spinal deformity in a subset of patients, with resultant worsening quality of life.^[@bibr4-2192568218799058]^ The goals of this study were first to describe the clinical features, disabilities and neurologic deficits of pyogenic spondylodiscitis on presentation, and second to compare the functional outcomes between patients who underwent medical and surgical management for pyogenic spondylodiscitis.

Methods {#section2-2192568218799058}
=======

Inclusion and Exclusion Criteria {#section3-2192568218799058}
--------------------------------

In an effort to maximize inclusion of relevant literature regarding medical and surgical management of primary pyogenic spondylodiscitis, the following inclusion criteria were used: (1) study must contain at least 10 patients, (2) the primary focus of the study must be surgical or medical management with reported outcome of spontaneous discitis, (3) article must be written in English, (4) the study must involve human subjects, and (5) the articles must be found in MEDLINE journal categories. Case reports, reviews, technical notes, or studies involving primarily pediatric patients (age \<18 years), vertebral abscess, iatrogenic discitis, or those focusing on one specific pathogen were excluded. If multiple studies were published by a single author, only the largest series was included.

Literature Search {#section4-2192568218799058}
-----------------

For the present systematic review, a focused search on PubMed was considered sufficient. A systematic review was performed on March 21, 2018 using PubMed with the following search term: ("discitis" OR "spondylodiscitis" OR "diskitis") and ("management" OR "treatment" OR "surgery" OR "surgical"). Results were restricted to Medline journal categories regarding human subjects and published in English, of which 1286 articles resulted. Article titles were evaluated to identify those related to the medical or surgical management and outcomes of discitis or vertebral osteomyelitis. Studies not meeting the aforementioned inclusion criteria were excluded ([Figure 1](#fig1-2192568218799058){ref-type="fig"}). A total of 111 abstracts were reviewed and application of inclusion criteria was repeated, which excluded an additional 55 studies. For the remaining 56 studies, we reviewed the full-text journal articles, and 48 achieved criteria for inclusion. Following, a search was performed on Cochrane Review for additional articles using the same inclusion and exclusion criteria, identifying 2 additional articles. Finally, 50 full-text journal articles were available for evaluation.

![Flowchart outlining the systematic review process. The initial PubMed search resulted in 1286 articles. Subsequent screening and application of inclusion and exclusion criteria yielded 50 total articles to undergo detailed review and pooling of data. Two additional articles were identified after similar process through Cochrane Review.](10.1177_2192568218799058-fig1){#fig1-2192568218799058}

Literature Review and Data Extraction {#section5-2192568218799058}
-------------------------------------

A protocol was registered with PROSPERO for this review (CRD42018092268), and the review follows the guidelines established by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).^[@bibr5-2192568218799058]^ When provided by the original article, demographic, clinical, pathological, surgical, and outcome data was extracted from selected studies. Demographic data included the number of patients, sex, age, and associated comorbidities. Clinical data included time to diagnosis, imaging modality, presenting symptoms, relevant laboratory values, culture source, and results. Outcome data included duration at follow-up, pain at follow-up, presence of neurologic deficits, and return to work. A composite score of excellent functional outcomes was created to capture the various reports of return to work with normal activity, freedom from pain at last follow-up, Oswestry Disability Index (ODI) score less than 20, or a Kirkaldy-Willis Score of 3 or greater. Surgery-specific series were further evaluated to determine type of surgery (decompression alone, decompression and fusion, combined anterior-posterior approach, or staged surgery).

Statistical Analysis {#section6-2192568218799058}
--------------------

Pooled data were gathered from all available articles and continuous variables were summarized with means calculated based on the numbers of patients pooled from each article. When available, comparison of pain outcomes after medical and surgical treatment versus medical treatment alone was performed using Review Manager (RevMan), version 5.3 (Copenhagen: The Nordic Cochrane Centre, the Cochrane Collaboration, 2012). Odds ratios for individual studies and the sum of studies were computed using the Mantel-Haenszel test. Mean difference was determined using RevMan as well. Study heterogeneity was detected using the chi-square and *I* ^[@bibr2-2192568218799058]^ test statistics. Given the limitations on the power of the chi-square test by the small number of studies in the analyses, significant heterogeneity was considered to be present when both the chi-square value was within 10% level of significance (*P* \< .10) or the *I* ^[@bibr2-2192568218799058]^ value exceeded 50%.

Results {#section7-2192568218799058}
=======

Study Selection {#section8-2192568218799058}
---------------

The search term resulted in 1286 articles for review. Among these, 111 articles were selected for further review of abstracts based on title and relevance to inclusion and exclusion criteria. Application of inclusion and exclusion criteria to study abstracts yielded 56 articles. The full-text articles for these 56 studies were then reviewed and subjected to our inclusion criteria, after which 48 articles were eligible for systematic review.^[@bibr3-2192568218799058],[@bibr6-2192568218799058][@bibr7-2192568218799058][@bibr8-2192568218799058][@bibr9-2192568218799058][@bibr10-2192568218799058][@bibr11-2192568218799058][@bibr12-2192568218799058][@bibr13-2192568218799058][@bibr14-2192568218799058][@bibr15-2192568218799058][@bibr16-2192568218799058][@bibr17-2192568218799058][@bibr18-2192568218799058][@bibr19-2192568218799058][@bibr20-2192568218799058][@bibr21-2192568218799058][@bibr22-2192568218799058][@bibr23-2192568218799058][@bibr24-2192568218799058][@bibr25-2192568218799058][@bibr26-2192568218799058][@bibr27-2192568218799058][@bibr28-2192568218799058][@bibr29-2192568218799058][@bibr30-2192568218799058][@bibr31-2192568218799058][@bibr32-2192568218799058][@bibr33-2192568218799058][@bibr34-2192568218799058][@bibr35-2192568218799058][@bibr36-2192568218799058][@bibr37-2192568218799058][@bibr38-2192568218799058][@bibr39-2192568218799058][@bibr40-2192568218799058][@bibr41-2192568218799058][@bibr42-2192568218799058][@bibr43-2192568218799058][@bibr44-2192568218799058][@bibr45-2192568218799058][@bibr46-2192568218799058][@bibr47-2192568218799058][@bibr48-2192568218799058][@bibr49-2192568218799058][@bibr50-2192568218799058][@bibr51-2192568218799058]-[@bibr52-2192568218799058]^ ([Figure 1](#fig1-2192568218799058){ref-type="fig"}) Following an additional search on Cochrane Review, 2 additional studies^[@bibr53-2192568218799058],[@bibr54-2192568218799058]^ were found, and a total of 50 articles were eligible for final systematic review ([Tables 1](#table1-2192568218799058){ref-type="table"} and [2](#table2-2192568218799058){ref-type="table"}) 16 studies reported both surgical and medical outcomes. All but 3 studies were retrospective in nature.

###### 

Summary of the 50 Studies Included in Pooled Data for Presenting Features of Pyogenic Spondylodiscitis.

![](10.1177_2192568218799058-table1)

                                                    Demographics   Presentation   Lesion Location                                 
  ------------------- ----------------------------- -------------- -------------- ----------------- ------ ----- ----- ---- ----- -----
  Aagaard, 2013       Retrospective review          100            37             60                32                 25   26    65
  Asamoto, 2005       Retrospective review          21             13             66                       19    12    5    7     11
  Ascione 2017        Retrospective review          30             13             64                28     30    5     0    2     20
  Bernard, 2015       Randomized controlled trial   351            242            61                       337   57    52   96    246
  Bettini, 2009       Retrospective review          56             21             48                34     56    18    3    8     48
  Butler, 2006        Retrospective review          48             24             59                       47    14    4    11    30
  Bydone, 2014        Retrospective review          118                           57                       67    61    35   40    43
  Cebrian, 2012       Retrospective review          108            49             68                       97    27    4    38    66
  Chung, 2011         Retrospective review          20             13             60                       20    14    0    8     12
  Citak, 2014         Retrospective review          183            99             63                             80    14   66    97
  D'Agostino, 2010    Prospective series            81             51             58                55.4   79    12    10   59    12
  D'Aliberti, 2012    Retrospective review          40             29             56                       39    16    13   18    9
  Dennis, 2017        Retrospective                 84             49             62                       68    19    29   79    156
  Eysel, 1997         Retrospective review          55             28             52                                               
  Ha, 2007            Retrospective review          24             14                                      23    7     0    0     24
  Hadjipavlou, 2000   Retrospective review          101            76             46                             40    10   33    55
  Heyde, 2006         Retrospective review          20             11             60                84           9                 
  Homagk, 2016        Retrospective review          270            153                              64           101   30   103   149
  Hopf, 1998          Retrospective review          72             39             52                                   0    40    49
  Karadimas, 2008     Retrospective review          163            101            56                                   13   72    88
  Kaya, 2014          Retrospective review          107            64             53                       97    18    7    14    90
  Kehrer, 2015        Retrospective review          298            182            66                             33    38   95    203
  Klockner, 2003      Retrospective review          71             38             54                             18    0    33    39
  Krodel, 1991        Retrospective review          24                            50                                               
  Legrand, 2001       Retrospective review          110            67             61                40           18    3    23    69
  Lemaignen, 2017     Retrospective review          394            267            63                40     369   130   71   137   281
  Lin CP, 2012        Retrospective review          48             19             67                144    48    28    0    16    38
  Lin TY, 2014        Retrospective review          45             25             62                                   0    9     36
  Lin Y, 2015         Retrospective review          22             13             55                       22    8     0    0     22
  Lu, 2015            Retrospective review          28             13             60                             6     0    2     28
  Mann, 2004          Prospective series            24             14             63                       24    13    4    10    10
  Nasto, 2014         Retrospective review          27             18             60                33                 0    5     22
  Noh, 2017           Retrospective review          31             27             68                       18          3    8     20
  Pee, 2008           Retrospective review          60             36             59                       58    16    0    0     60
  Rath, 1996          Retrospective review          43             24             60                46           35    0    19    24
  Shinkel, 2003       Retrospective review          32             18             61                       32    17    21   19    35
  Schomacher, 2014    Retrospective review          37             24             62                       37          6    6     25
  Shetty, 2016        Retrospective review          27             19             48                             6                 
  Shiban, 2014        Retrospective review          113            78                                      104   40                
  Shousha, 2012       Retrospective review          30             19             65                       24    12    30   0     0
  Sobottke, 2009      Retrospective review          20             14             43                23           3     2    6     12
  Srinivasan, 2014    Retrospective review          48             29             56                                               
  Suess, 2007         Retrospective review          24             15             65                9      24    7     3    14    7
  Tsai, 2017          Retrospective review          90             61             61                                               
  Valancius, 2013     Retrospective review          196            106                              52.5   177   47    9    42    125
  Vcelak, 2014        Retrospective review          31             20             61                             9          6     25
  Viale, 2009         Prospective series            48             36             60                             9     6    9     29
  Wirtz, 2000         Retrospective review          59             29             61                90     46                     
  Yaldz, 2015         Retrospective review          39             19             47                105    37    18    0    15    24
  Ziu, 2014           Retrospective review          102            87             45                       102   26    9    24    59

![](10.1177_2192568218799058-table2)

                      Surgical Treatment   Follow-up                            
  ------------------- -------------------- ----------- ---- ---- ---- ---- ---- ----
  Aagaard, 2013                            94          3    26                  
  Asamoto, 2005                            21                              11   11
  Ascione, 2017                            30          30   8         22   4    22
  Bernard, 2015                            283         12   10                  
  Bettini, 2009       3                    56          12                       
  Butler, 2006                                              0                   
  Bydone, 2014        118                              15   23                  
  Cebrian, 2012                            108         6              35        35
  Chung, 2014         20                   20          36   4    20   20        20
  Citak, 2011         102                  183                                  
  D'Agostino, 2010    10                   72                                   65
  D'Aliberti, 2012    40                   40          43   13        17        17
  Eysel, 1997         55                               42                       
  Ha, 2007                                                  1                   
  Hadjipavlou, 2000   62                   47               14                  
  Heyde, 2006                                          37   3                   
  Homagk, 2016                                                                  
  Hopf, 1998                               72          38   1                   
  Karadimas, 2008     93                   163         12   22                  
  Kaya, 2014                                                               94   94
  Klockner, 2003      71                   71          64                       
  Krodel, 1991                                         36                       
  Legrand, 2001                            99          3                   42   42
  Lemaignen, 2017     58                   378         5    26                  
  Lin CP, 2012        48                   48          64        32        32   32
  Lin TY, 2014        45                   45          24                       
  Lin Y, 2015         22                   22          31   0              19   19
  Lu, 2015            28                   28          20   0    10        15   25
  Mann, 2004                               24                    15             15
  Nasto, 2014         12                   27          9                        
  Pee, 2008           60                   60          36   5                   
  Rath, 1996          45                   41               15                  
  Shinkel, 2003       32                   20          49   10                  
  Schomacher, 2014    37                   37          20                       
  Shiban, 2014        106                              3    16                  
  Shousha, 2012       30                   27          28                       
  Sobottke, 2009                           11          13                       
  Srinivasan, 2014                         48                                   
  Suess, 2007         24                   24          18                       
  Tsai, 2017          43                                                        
  Valancius, 2013     117                  80          12             64        64
  Vcelak, 2014        31                   30          12                  27   27
  Wirtz, 2000                              59          26                       
  Yaldz, 2015         12                   39          96   1                   
  Ziu, 2014           24                   66          7                        

Demographic and Presenting Clinical Data {#section9-2192568218799058}
----------------------------------------

Demographic and clinical data for the 4173 patients from the 50 studies included in this systematic review are summarized in [Table 3](#table3-2192568218799058){ref-type="table"}. The mean patient age at presentation was 58.3 years, and 60% of the patients were men. The mean time to diagnosis from initial symptom onset was 54.93 days. Back pain was the most commonly reported presenting symptom, occurring in 91% (2101/2299) of patients. Other commonly observed findings included fever (35%, 748/2125) and focal neurologic deficits (29%, 1009/3422. Among the patients treated surgically, back pain (88%, 674/770) and focal neurologic deficits (39%, 475/1224) were the most commonly reported findings. Concurrent infection (35%, 207/834) and cardiovascular disease (24%, 260/1083) were the most common comorbidities associated with infectious discitis. Other common comorbidities included intravenous drug abuse (IVDA) (15%, 226/1379), diabetes mellitus (20%, 651/3272), immunosuppression (11%, 274/2429), and end stage renal disease (9%, 111/1263) ([Table 3](#table3-2192568218799058){ref-type="table"}).

![](10.1177_2192568218799058-table3)

  Demographic and Clinical Data (n = Number of Studies)                    
  ------------------------------------------------------- -------- ------- ---------
  No. of patients (n = 50)                                4173             
  Percent men (n = 48)                                    60               
  Age (years) (n = 46)                                    58.28            
  Time to diagnosis (days) (n = 16)                       54.93            
  Length of follow-up (months) (n = 33)                   26.14            
  Comorbidities                                           Number   Total   Percent
  Concurrent infection (n = 14)                           207      834     35
  Cardiovascular disease (n = 13)                         260      1083    24
  Intravenous drug abuse (n = 14)                         226      1379    15
  Diabetes (n = 33)                                       651      3727    20
  Immunosuppression (n = 20)                              274      2429    11
  End-stage renal disease (n = 17)                        111      1263    9
  Back pain on presentation (n = 28)                      2101     2299    91
  Fever on presentation (n = 21)                          748      2125    35
  Neurologic deficits on presentation (n = 38)            1009     3422    29

Laboratory and diagnostic data are summarized in [Table 4](#table4-2192568218799058){ref-type="table"}. C-reactive protein (CRP) was elevated (\>10 mg/L) in 85% (1083/1272) of patients, and erythrocyte sedimentation rate (ESR) was elevated in 69% (464/672) of patients. Leukocytosis was found in 43% (457/1052) of patients. Magnetic resonance imaging (MRI) and nuclear bone scan were diagnostic in 94% (980/1045) and 93% (14/15) of patients, respectively. Computed tomography (CT) was positive in in 87% (127/146) of patients and plain radiographs in 70% (129/185) of patients. Infection occurred in the cervical region in 12% of reported sites (459/3824), 31% in the thoracic spine (1219/3919), and 62% in the lumbar spine (2463/3943). Blood cultures were positive in only 51% of 930 reported cases, compared to 57% (149/261) of percutaneous biopsies and 58% (296/511) of surgical biopsies. Commonly isolated pathogens were *Staphylococcus aureus* (38%, 1268/3360), *Mycobacterium tuberculosis* (15%, 126/866), and *Streptococcus* species (12%, 181/1472). Blood cultures were negative in 28% of cases ([Table 4](#table4-2192568218799058){ref-type="table"}).

![](10.1177_2192568218799058-table4)

  Laboratory and Diagnostic Data (n = Number of Studies)   Number   Total   Percent
  -------------------------------------------------------- -------- ------- ---------
  Imaging                                                                   
  MRI positive (n = 14)                                    980      1045    94
  Bone scan positive (n = 1)                               14       15      93
  CT positive (n = 4)                                      127      146     87
  X-ray positive (n = 4)                                   129      185     70
  Levels involved                                                           
   Cervical (n = 40)                                       459      3824    12
   Thoracic (n = 42)                                       1219     3919    31
   Lumbar (n = 42)                                         2863     3943    62
   Associated abscess (n = 18)                             567      1924    29
  Labs                                                                      
   Elevated CRP (\>10 mg/L) (n = 16)                       1083     1272    85
   Elevated ESR (\>20 mm/h) (n = 12)                       464      672     69
   Leukocytosis (n = 16)                                   457      1052    43
  Culture yield                                                             
   Surgical biopsy positive (n = 13)                       296      511     58
   Percutaneous biopsy positive (n = 8)                    149      261     57
   Blood culture positive (n = 13)                         475      930     51
   Negative cultures (n = 27)                              447      1583    28
  Culture results                                                           
   *Staphylococcus aureus* (n = 42)                        1268     3360    38
   *Mycobacterium tuberculosis* (n = 23)                   126      866     15
   Gram-negative rods (n = 28)                             214      1810    12
  Streptococcus (n = 26)                                   181      1472    12
  Enterococcus (n = 22)                                    55       913     6

Abbreviations: CRP, C-reactive protein; CT, computed tomography; ESR, erythrocyte sedimentation rate; MRI, magnetic resonance imaging.

Treatment and Outcomes {#section10-2192568218799058}
----------------------

Decompression with instrumented fusion was the most commonly performed intervention reported (79%, 1049/1321), compared to decompression alone (22%, 223/1024) based on the respective series reporting each variable. Combined anterior and posterior approach was performed in 33% (448/1364) of surgical patients, and staged surgery was performed in 26% (128/485) of surgical patients. Repeat surgery was necessary in 13% (119/891) of patients among the surgery-specific series ([Table 5](#table5-2192568218799058){ref-type="table"}).

###### 

Surgical Procedures Performed Among Surgical Reports.

![](10.1177_2192568218799058-table5)

  Surgery Demographics (n = Number of Studies)                Number   Total   Percent
  ----------------------------------------------------------- -------- ------- ---------
  Decompression and fusion among surgical patients (n = 27)   1049     1321    79
  Treated surgically (n = 46)                                 2133     3384    63
  Decompression alone among surgical patients (n = 22)        223      1024    22
  Anterior and posterior combined approach (n = 22)           448      1364    33
  Staged surgery (n = 13)                                     128      485     26
  Reoperation rate (n = 24)                                   119      891     13

Follow-up was reported in 33 articles, with an average follow-up of 26.14 months. Outcome was reported in various ways (no pain, treatment success, etc), but functional outcome was reported sparingly and using various metrics (return to work, ODI, visual analog scale \[VAS\] score, Kirkaldy-Willis \[KW\]). Four studies (all surgical) reported return-to-work outcomes, with 88% (83/94) of patients reported as returning to normal work activities at last follow-up. Neurologic deficits decreased among all patients from 29% at presentation to 12% at follow-up, and from 39% among all surgical patients to 15% at follow-up. A composite score was made to identify all patients with a KW score of 3 or greater, ODI \<20%, pain freedom, or return to normal work status. Excellent functional outcomes were reported in 73% (895/1234) of all patients, and in 68% (376/555) of surgical patients. Mortality rate was 8% among all patients, and 6% among surgical patients.

Two studies reported pain outcome of surgical and medical management cohorts separately at last follow-up, with 85% (50/59) of surgical patients reporting freedom from pain compared with 52% (37/72) of medical patients (odds ratio \[OR\] 5.35, CI 2.27-12.60, *P* \< .001)^[@bibr6-2192568218799058],[@bibr20-2192568218799058]^ ([Figure 2](#fig2-2192568218799058){ref-type="fig"}). Two articles also reported VAS at follow-up in medical and surgical patients, with surgical patients experiencing a significantly lower VAS score compared with medical patients (mean difference −0.61, CI −0.98 to −0.25).^[@bibr35-2192568218799058],[@bibr47-2192568218799058]^ Significant study heterogeneity was observed in both meta-analyses ([Figures 2](#fig1-2192568218799058){ref-type="fig"} and [3](#fig3-2192568218799058){ref-type="fig"}).

![Forest plot of the odds ratios (ORs) of pain free outcomes among surgical and medical cohorts with infectious spondylodiscitis. The estimated OR and 95% confidence interval (CI) of each included study are represented by the center of the squares and the horizontal line, respectively. The summary OR and 95% CI are represented by the diamond. Heterogeneity and overall effect are given below the summary statistics.](10.1177_2192568218799058-fig2){#fig2-2192568218799058}

![Forest plot of the mean difference in visual analog score among surgical and medical cohorts with infectious spondylodiscitis. The estimated mean difference and 95% confidence interval (CI) of each included study are represented by the center of the squares and the horizontal line, respectively. The summary mean difference and 95% CI are represented by the diamond. Heterogeneity and overall effect are given below the summary statistics.](10.1177_2192568218799058-fig3){#fig3-2192568218799058}

Discussion {#section11-2192568218799058}
==========

Spondylodiscitis is an infectious disease of the intervertebral disc space and adjacent bone that occurs secondary to hematogenous seeding or direct spread from an adjacent infection site.^[@bibr1-2192568218799058]^ Though epidural abscess may be seen in patients with pyogenic discitis, neurologic symptoms in the setting of abscesses are often dealt with through prompt surgical evacuation and not necessarily as a means of source control, spinal stabilization, or resolution of infection, and thus must be thought of separately from management of vertebral osteomyelitis and discitis.^[@bibr55-2192568218799058]^ Thus, we did not include articles primarily discussing management of epidural abscess.

In the pathogenesis of discitis, bacteria seed the arterioles of the vertebral end plates, resulting in pathogen deposition into the relatively avascular intervertebral disc or adjacent vertebral endplate.^[@bibr2-2192568218799058],[@bibr8-2192568218799058]^ The poor vascularity of this region results in a relatively safe haven for seeding bacteria and consequently often requires prolonged antibiotic treatment.^[@bibr8-2192568218799058],[@bibr56-2192568218799058]^ This can be complicated by the natural history of osteomyelitis (a frequent accompanying feature of discitis), in which bacterial growth and purulence within vascular channels results in increased intraosseous pressure and further worsening blood flow.^[@bibr57-2192568218799058]^

Diagnosis of discitis begins with the clinical presentation, whereby the vast majority of patients (91% in this series) present with back pain. Serum studies have low specificity for disease and may be unreliable in diagnosis.^[@bibr57-2192568218799058]^ Still, ESR and CRP are frequently elevated, and C-reactive protein levels may be useful in determining clinical response after diagnosis is made.^[@bibr57-2192568218799058]^ Ultimately diagnosis requires advanced imaging, with MRI demonstrating superiority in specificity compared with CT.^[@bibr1-2192568218799058],[@bibr57-2192568218799058],[@bibr58-2192568218799058]^ Antibiotics are typically withheld until after percutaneous or surgical biopsy has been performed, unless a patient demonstrates evidence of septicemia or neurologic deficit.^[@bibr56-2192568218799058]^ Withholding antibiotics is of particular importance as biopsy yield can decrease considerably following initiation of antibiotics.^[@bibr56-2192568218799058]^ *Staphylococcus aureus* was the most common organisms isolated among pyogenic causes of discitis. This organism was found in 38% of the cases in this systematic review. Of particular concern with pyogenic discitis is the rising prevalence of methicillin-resistant species of *Staph aureus* and the implications associated with prolonged disease due to poor bone penetrance of vancomycin.^[@bibr2-2192568218799058]^

With treatment resistant pathogens arises the possibility of prolonged infection and continued destruction of the vertebral end plates and disc, which can result in progressive spinal deformity and poor functional outcomes.^[@bibr1-2192568218799058],[@bibr4-2192568218799058],[@bibr56-2192568218799058],[@bibr57-2192568218799058],[@bibr59-2192568218799058]^ Among historical series, in which tuberculosis accounted for a substantial portion of spondylodiscitis cases, as many as 61% of patients developed spinal deformity.^[@bibr2-2192568218799058],[@bibr8-2192568218799058]^ With further osseous and discoligamentous destruction and deformity, kyphosis and worsened focal spinal alignment may result in increased back pain and overall global sagittal malalignment, which has been repeatedly shown to increase disability scores and reduce quality of life.^[@bibr60-2192568218799058]^ Among patients with deformity, and in particular segmental kyphosis, surgery offers an opportunity for debridement, source control, and correction of deformity.

Unfortunately, reporting of functional outcome or return-to-work data among both medical and surgical literature is lacking. In the current review functional outcomes were reported in only 20 studies (13 surgical) and return to work status was reported in only 4 studies.^[@bibr3-2192568218799058],[@bibr13-2192568218799058],[@bibr34-2192568218799058],[@bibr41-2192568218799058]^ Among the included surgical series, 88% of patients were able to return to normal work activity. Surgical patients experienced excellent outcomes in 68% of those reported at follow-up, which is comparable to all patients where an excellent outcome was achieved in 73% of patients. Pain outcomes and VAS scores for both surgical and medical management were investigated by 2 separate meta-analyses. While the results from the available data suggest improved pain ratings with surgery compared with the medical treatment alone, significant heterogeneity (*I* ^[@bibr2-2192568218799058]^ = 56%, *P* = .13; *I* ^[@bibr2-2192568218799058]^ = 0%, *P* = .43) was detected in both studies preventing definitive determination of the influence of surgery on pain outcomes. For both analyses, these results can be attributed to the small sample sizes and it must be noted that lack of control of treatment strategy (operative vs nonoperative) and surgical procedure performed further obscures interpretation of outcome data.

The reports by Nasto et al^[@bibr35-2192568218799058]^ and Tsai et al^[@bibr47-2192568218799058]^ suggest a more rapid recovery and improvement in functional scores following surgery when compared with medical treatment alone, but with diminishing significance over time. These results suggest that surgery may have a role in enhancing patient's short-term recovery but may be unlikely to change long-term results as most patients will have substantial improvement in back pain regardless of treatment modality. Lemaignen et al^[@bibr30-2192568218799058]^ also demonstrated that surgery was protective of functional outcome on univariate analysis but not on multivariate analysis. These findings support the need for additional research to delineate what role surgery may have in improving functional outcomes.

This study is also limited by the availability of pooled data from mostly retrospective studies, each with their own inherent biases and a general lack of uniformity in reporting of outcomes. The lack of consistent reporting of outcomes for surgical and medical series, as well as for particular surgical procedures (instrumentation vs decompression alone), limits our ability to perform further meta-analysis or subgroup analysis. Furthermore, the retrospective case series may suffer from selection bias as patients who were treated surgically tended to be those who suffered intractable back pain, neurologic deficit or progressive spinal deformity, and thus outcome comparison between medical and surgical treatments may be inherently biased. Furthermore, the limitation of the search to English may lead to reporting bias. No randomized studies were identified in this literature review comparing surgical and medical therapies. Future prospective studies limiting comparison of surgical and medical patients to those with similar clinical features may reduce errors due to selection bias and provide further insight into clinical outcomes.

Conclusions {#section12-2192568218799058}
===========

Spondylodiscitis is a disease with increasing prevalence that can result in poor functional outcome and progressive spinal deformity. According to this study, most patients with spondylodiscitis present with back pain. MRI and bone scan are the most sensitive imaging modalities for detecting infectious spondylodiscitis, and *Staph aureus* is the most common organism isolated from cultures. Medical treatment is often first-line management for infectious discitis, but surgery may be indicated in cases of significant or worsening neurologic deficit, recalcitrant infections, or progressive spinal deformity. Functional outcomes suggest surgery may result in a greater reduction in pain compared to medical treatment alone, but substantial patient heterogeneity prevents definitive conclusions. Further, this meta-analysis included retrospective studies, and so its conclusions should be interpreted with caution. Direct comparison in prospective trials is needed to reduce selection bias and definitively determine the appropriate treatment algorithm.
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